Why the study?
Cardiovascular diseases are largely preventable yet carry high incidence and mortality, prompting this pilot study to gain information on the lifestyle of patients receiving anticoagulation therapy.
Cross-Sectional (n=39)
Yes
Patients on anticoagulation for atrial fibrillation frequently exhibit high-risk lifestyle factors such as obesity and inadequate implementation of healthy lifestyle education, highlighting a gap in secondary prevention.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Zatloukalová et al. (2020) conducted a cross-sectional in Atrial fibrillation requiring anticoagulant therapy (n=39). Anticoagulant treatment (warfarin or DOACs) was evaluated on Lifestyle characteristics (BMI, comorbidities, and health education).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: